Anthion Partners II Buys ~700K Shares of KaloBios Pharma (KBIO), Adding to Madness
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Macrocure (MCUR) Ramps Higher
November 20, 2015 10:47 AM ESTMacrocure (NASDAQ: MCUR) shares advanced Friday, rising 50%. Some traders tied the moved to recent gains in KaloBios Pharma (NASDAQ: KBIO) and Macrocure's 'thin' 6.2 million share float.
... MoreShock of Epic Short Squeeze in KaloBios Pharma (KBIO) Reverberates Across Wall Street
November 19, 2015 1:36 PM ESTThe stock being talked about the most on trading desks today is KaloBios Pharma (NASDAQ: KBIO). After closing at around $2 per share, shares surged to as high as $21.05 (+953%) following a disclosure after the close from Turing Pharmaceuticals' Martin Shkreli, a man demonized for jacking up drug prices, that he accumulated 1.2 million shares.
$2... $4... $6... $10... $12... shares keep climbing as short sellers were left stunned.
You see, just... More
Market Wrap: Fed Hints at Dec. Hike; China Trims Treasury Holdings; Housing Starts Lags in Oct.; Apple Gains on Goldman Call
November 18, 2015 5:26 PM ESTMarket wrap for November 18th
End of the Day: S&P 500 up 33.1 to 2,083.58; Dow Jones up 247.7 to 17,737.16; Nasdaq up 89.2 to 5,075.20
Market Brief: China lowered its U.S. Treasury holdings to $1.258 trillion, which was the lowest level seen in seven months, while Japan cut its stake to $1.17 trillion, the lowest in nearly two years.
The FOMC indicated that a rate hike might be coming in December, according to the minutes from its latest meeting.
Apple moved higher following... More
Celladon (CLDN) Moves Higher in Concert with KaloBios Pharma (KBIO) Following Shkreli Stake
November 18, 2015 5:24 PM ESTCelladon (Nasdaq: CLDN) shares are ticking higher in sympathy with KaloBios Pharma (Nasdaq: KBIO).
After markets closed, Martin Shkreli disclosed taking a massive stake in KaloBios. For more color, click here.
Earlier this year, Celladon announced plans to explore alternatives. The stock is up over 20 percent late Wednesday.
... MoreWith Shkreli Spike, KaloBios Pharma (KBIO) May Be Overvalued by a Factor of 4
November 18, 2015 4:57 PM ESTThe upside being seen in KaloBios Pharma (NASDAQ: KBIO) after the close (400%+) after Martin Shkreli... More
KaloBios Pharma (KBIO) Pops on Shkreli Insider Buy
November 18, 2015 4:25 PM ESTKaloBios Pharma (NASDAQ: KBIO) ripping higher as Martin Shkreli purchased shares.
Shkreli disclosed buying 1,211,115 shares from November 16, 2015-November 17, 2015. Prices paid ranged from $0.61-$2.43.
On November 13, 2015, KaloBios announced that it will wind down its operations and that it has engaged the Brenner... More
